However, IL-33 driven inflammation is a double-edged sword capable of prolonging inflammation and inducing tissue damage, as portrayed in asthma and allergy, and precise modulation is essential to sustain homeostasis, and herein lies the potential therapeutic role of miRNAs. The gene discussed is IL33; the disease is allergic disease.